- Vaccines
- Antibiotics
- Antifungals
- Parasiticides
- Anti-Viral Drugs
- Others
Europe Swine Feed Market report gives a comprehensive outlook across the globe with special emphasis on key countries such as United Kingdom, Spain, Italy, Germany and the Rest of europe. The report gives historical, current, and future market sizes (US$ Mn) on the basis of feed type, feed additive type, feed essence and region. This report studies Europe Swine Feed Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged.
Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. Swine healthcare becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases.
Key Developments:
In September 2015, Boehringer Ingelheim Animal Health launched ingelvac PRRSFLEX EU for piglets and ReproCyc PRRS EU for sows for control of reproductive and respiratory syndrome.
Europe Swine Healthcare Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
X%
Largest Market
N/A
Fastest Growing Market
N/A
Europe Swine Healthcare Market
Europe Swin e Healthcare Market Drivers are High demand for healthy pork meat coupled with increase in pork meat production, Rise in prevalence of various infectious and foodborne diseases and Increase in the R&D activities for the innovation of novel therapeutics and feed products. Restraints are Stringent regulatory guidelines for the swine vaccines and drug approvals and Adverse effects associated with the drugs.
Europe Swine Healthcare Market
Europe Swine Healthcare Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Europe Swine Healthcare Market Segmentation
By Drugs
By Feed Products
- Nutritional Feed
- Medicated Feed
- Non-Medicated Feed
By Disease Type
- Viral Infections
- Bacterial Infections
- Parasitic Infection
- Fungal Infections
By Route-Administration
- Oral
- Parenteral
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
The Europe Swine Healthcare Market Report data: (Europe, Germany, France, Italy, United Kingdom (UK), Spain, Rest of EU)
The Europe Swine Healthcare Market key players are: Zoetis (Pfizer, Inc.) (U.S.) Merck & Co. Inc. (U.S) Virbac S.A. (France) Boehringer Ingelheim Vetmedica (Germany) Elanco (U.S.) Bayer Animal Health (Germany) Ceva Sante Animale (France) Wilbur-Ellis Feed, LLC (U.S.) Vetoquinol S.A. (France)
| 1. Executive Summary |
| 2. Europe Swine Healthcare Market Introduction |
| 2.1. Europe Swine Healthcare Market - Taxonomy |
| 2.2. Europe Swine Healthcare Market - Definitions |
| 2.2.1. Drugs |
| 2.2.2.Feed Products |
| 2.2.3.Disease Type |
| 2.2.4.Route-Administration |
| 2.2.5.Region |
| 3. Europe Swine Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Swine Healthcare Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Swine Healthcare Market By Drugs, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Vaccines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Antibiotics |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Antifungals |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Parasiticides |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Anti-Viral Drugs |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Europe Swine Healthcare Market By Feed Products, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Nutritional Feed |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Medicated Feed |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Non-Medicated Feed |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Europe Swine Healthcare Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Viral Infections |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Bacterial Infections |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Parasitic Infection |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Fungal Infections |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Europe Swine Healthcare Market By Route-Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Oral |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Parenteral |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9. Europe Swine Healthcare Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Europe |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Germany |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. France |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Italy |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. United Kingdom (UK) |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Spain |
| 9.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.6.3. Market Opportunity Analysis |
| 9.7. Rest of EU |
| 9.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.7.3. Market Opportunity Analysis |
| 10.Europe Europe Swine Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Vaccines |
| 10.1.2.Antibiotics |
| 10.1.3.Antifungals |
| 10.1.4.Parasiticides |
| 10.1.5.Anti-Viral Drugs |
| 10.1.6.Others |
| 10.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Nutritional Feed |
| 10.2.2.Medicated Feed |
| 10.2.3.Non-Medicated Feed |
| 10.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Viral Infections |
| 10.3.2.Bacterial Infections |
| 10.3.3.Parasitic Infection |
| 10.3.4.Fungal Infections |
| 10.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Oral |
| 10.4.2.Parenteral |
| 11. Germany Europe Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Vaccines |
| 11.1.2.Antibiotics |
| 11.1.3.Antifungals |
| 11.1.4.Parasiticides |
| 11.1.5.Anti-Viral Drugs |
| 11.1.6.Others |
| 11.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Nutritional Feed |
| 11.2.2.Medicated Feed |
| 11.2.3.Non-Medicated Feed |
| 11.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Viral Infections |
| 11.3.2.Bacterial Infections |
| 11.3.3.Parasitic Infection |
| 11.3.4.Fungal Infections |
| 11.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Oral |
| 11.4.2.Parenteral |
| 12. France Europe Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Vaccines |
| 12.1.2.Antibiotics |
| 12.1.3.Antifungals |
| 12.1.4.Parasiticides |
| 12.1.5.Anti-Viral Drugs |
| 12.1.6.Others |
| 12.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Nutritional Feed |
| 12.2.2.Medicated Feed |
| 12.2.3.Non-Medicated Feed |
| 12.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Viral Infections |
| 12.3.2.Bacterial Infections |
| 12.3.3.Parasitic Infection |
| 12.3.4.Fungal Infections |
| 12.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Oral |
| 12.4.2.Parenteral |
| 13. Italy Europe Swine Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Vaccines |
| 13.1.2.Antibiotics |
| 13.1.3.Antifungals |
| 13.1.4.Parasiticides |
| 13.1.5.Anti-Viral Drugs |
| 13.1.6.Others |
| 13.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Nutritional Feed |
| 13.2.2.Medicated Feed |
| 13.2.3.Non-Medicated Feed |
| 13.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Viral Infections |
| 13.3.2.Bacterial Infections |
| 13.3.3.Parasitic Infection |
| 13.3.4.Fungal Infections |
| 13.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Oral |
| 13.4.2.Parenteral |
| 14.United Kingdom (UK) Europe Swine Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Vaccines |
| 14.1.2.Antibiotics |
| 14.1.3.Antifungals |
| 14.1.4.Parasiticides |
| 14.1.5.Anti-Viral Drugs |
| 14.1.6.Others |
| 14.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Nutritional Feed |
| 14.2.2.Medicated Feed |
| 14.2.3.Non-Medicated Feed |
| 14.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Viral Infections |
| 14.3.2.Bacterial Infections |
| 14.3.3.Parasitic Infection |
| 14.3.4.Fungal Infections |
| 14.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Oral |
| 14.4.2.Parenteral |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 15.2.2.Merck & Co. Inc. (U.S) |
| 15.2.3.Virbac S.A. (France) |
| 15.2.4.Boehringer Ingelheim Vetmedica (Germany) |
| 15.2.5.Elanco (U.S.) |
| 15.2.6.Bayer Animal Health (Germany) |
| 15.2.7.Ceva Sante Animale (France) |
| 15.2.8. Wilbur-Ellis Feed, LLC (U.S.) |
| 15.2.9.Vetoquinol S.A. (France) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Zoetis (Pfizer, Inc.) (U.S.)
- Merck & Co. Inc. (U.S)
- Virbac S.A. (France)
- Boehringer Ingelheim Vetmedica (Germany)
- Elanco (U.S.)
- Bayer Animal Health (Germany)
- Ceva Sante Animale (France)
- Wilbur-Ellis Feed, LLC (U.S.)
- Vetoquinol S.A. (France)